CORREA, NICOLI D.G.SILVA, FELIPE D.VIEIRA, DANIEL P.SOARES, CARLOS R.J.QUEIROZ, ALVARO A.A. de2022-05-052022-05-052022CORREA, NICOLI D.G.; SILVA, FELIPE D.; VIEIRA, DANIEL P.; SOARES, CARLOS R.J.; QUEIROZ, ALVARO A.A. de. In vitro cytotoxic data on Se-methylselenocysteine conjugated to dendritic poly(glycerol) against human squamous carcinoma cells. <b>Journal of Biomaterials Science, Polymer Edition</b>, v. 33, n. 5, p. 651-667, 2022. DOI: <a href="https://dx.doi.org/10.1080/09205063.2021.2008788">10.1080/09205063.2021.2008788</a>. Disponível em: http://repositorio.ipen.br/handle/123456789/33036.0920-5063http://repositorio.ipen.br/handle/123456789/33036Polymeric nanoparticles acting as sources of selenium (Se) are currently an interesting topic in cancer chemotherapy. In this study, polyglycerol dendrimer (DPGLy) was functionalized with seleno-methyl-selenocysteine (SeMeCys) by means of Steglich esterification with 4-dimethylaminopyridine/(l-ethyl-3-(3-dimethylaminopropyl)carbodiimide) (EDC/DMAP) and cerium chloride as cocatalyst in acetonitrile at quantitative yields of 98 ± 1%. The SeMeCys coupling DPGLy efficiency vs. time were determined by Fourier Transform infrared spectroscopy (FTIR) and ultraviolet–visible (UV–Vis) spectroscopy. The cytotoxic effects of SeMeCys–DPGLy on the Chinese Hamster ovary cell line (CHO-K1) and head and neck squamous cell carcinoma (HNSCC) cells line were assessed by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay. No signs of general toxicity of SeMeCys–DPGLy against CHO-K1 cells were detectable at which cell viability was greater than 98%. MTS assays revealed that SeMeCys–DPGLy reduced HNSCC cell viability and proliferation at higher doses and long incubation times.651-667openAccessseleniumdendrimersglyceroltoxicitycarcinomasbioassayin vitroIn vitro cytotoxic data on Se-methylselenocysteine conjugated to dendritic poly(glycerol) against human squamous carcinoma cellsArtigo de periódico53310.1080/09205063.2021.20087880000-0002-0007-534Xhttps://orcid.org/0000-0002-7982-1789https://orcid.org/0000-0002-0007-534X50.365.5